CHINA LEX PHARMA LAW NEWSLETTER
Vol. 2 , No.29 - November 5, 2001
TOPICS THIS ISSUE:
- Export of Medicine Figures from January to September
- China Recognizes the Danger of Sexual Transfer of AIDS
- UNIDO and Bio-Medicine Park to Build Medicine Research Center
- U.S. Summit Company and Matritech to Distribute Cancer Tests in the PRC
- List of China GMP Facilities (Continued)
Export of Medicine Figures from January to September
Item | Export Volume (Ton) | Y-o-y chg (%) |
Total | 161,092 | 12.4 |
Antibiotics
(not including preparations) | 20,255 | 5.3 |
TCM | 8,858 | -4.7 |
Medical dressing | 46,866 | 12.8 |
Item | Export value (USD) | Y-o-y chg (%) |
Total | 1,461,985,000 | 10.1 |
Antibiotics
(not including preparations) | 388,392,000 | 7.6 |
TCM | 67,320,000 | 5.8 |
Medical dressing | 06,773,000 | 7.4 |
(Source: Xinhua News Agency)
China Recognizes the Danger of Sexual Transfer of AIDS
The number of new AIDS cases in China recorded in the first nine months of 2002 has already exceeded the total number of cases reported in all of last year.
5,616 new cases were officially reported, raising the total number of known AIDS cases in China to 28,133. However, experts believe the number to be closer to around 600,000 and that by 2010, the number of infected Chinese people could be as high as 20 million.
"This is not a sanguine picture. The infection keeps rising in a quick manner," Vice Minister Yin Dakui said.
Health officials have said that although the use of used syringes is still the most common method of spreading the disease, the rate of homosexuality is "alarming" and sexual transmission is likely to overtake IV drug use as the major cause of infection.
Vice Minister Yin said "We must pay important attention to the spread of AIDS through our country's homosexual community and cannot be lax in strengthening education among the high-risk homosexual community."
It was reported that approximately 10,000 of the estimated 600,000 HIV/AIDS carriers have been infected through homosexual activities.
However, because only 28,133 cases have been officially reported in China since 1985, the official numbers of AIDS-related deaths is only 641.
Just this year, Chinese health authorities have admitted homosexuality is not a mental disease, and there has been increasing general acknowledgment of the sexual practice.
Zeng Yi, an AIDS researcher at the China Academy of Social Sciences said that although "shared syringes used for drug use remain the major cause of AIDS in China, the major mode of transfer may become sexual transfer as seen in developed nations presently."
(Source: Agence France Presse)
UNIDO and Bio-Medicine Park to Build Medicine Research Center
Liuyang Bio-Medicine Park and the United Nations Industrial Development Organization (UNIDO) have agreed to cooperate in the building of an international medicine research center in the central China province of Hunan.
The two sides signed an agreement in mid-October, making the project the first medicine industrial park with which UNIDO has become involved in China. It is also the first time that there has been an agreement between China's pharmaceutical industry and a United Nation's organization.
The province of Hunan is one of China's five leading producers of medicine. It is ranked second in the country according to natural medicinal reserves.
The cooperation between UNIDO and Liuyang Bio-Medicine Park, established in October 1998 and home to 31 medicine-related businesses, is hoped to facilitate communication and market penetration of Chinese and international medicine companies in the local and international market.
(Source: Xinhua News Agency)
U.S. Summit Company and Matritech to Distribute Cancer Tests in the PRC
Matritech Selects U.S. Summit Company To Distribute BladderChek Cancer Test Throughout People's Republic of China;
Matritech Inc. recently announced an agreement with the U.S. Summit Company to supply its BladderChek cancer detection product to Chinese hospitals and pharmacies.
The recent move is an extension of the agreement between the U.S. Summit Company and Matritech signed earlier this year for exclusive distribution rights in Indonesia, Malaysia, Singapore, Taiwan and Thailand.
U.S. Summit, one of the largest Asian medical distributors with annual sales of more than $300 million, is also one the exclusive distributors for Merck and American Home Products. Matritech is one of the leading developers of proteomics-based diagnostic products for the early detection of cancer.
Stephen Ip, Matritech vice president for Asia said "The People's Republic of China is a very important market for Matritech, and U.S. Summit is an excellent partner that understands the Asian market. As part of our agreement, U.S. Summit has developed an impressive marketing plan for NMP22 BladderChek and is committed to obtaining Chinese government SDA approval for the product."
(Source: Healthwire)
VISITING US IN BEIJING?
Turn Your PDA Into A Tour Guide
Beijing City guide for Palm OS 3.5
1000 Chinese Character TAXI Cards
1000 Super descriptions ONLY US $18.95
www.redBANG.com
NEVER EVER LOST
What the professionals have said:
I tried the redBANG application,
It is the most thorough guide I've seen!
Ava Mason
Handango Business Development
List of China GMP Facilities (Continued)
Name of Enterprise | Certified Scope |
301. Changshu Leirunshang Pharmaceutical Co., Ltd. | High Dose Injection, Low Dose Injection |
302. Shijiazhuang 4th Pharmaceutical Co., Ltd. | High Dose Injection |
303. Zhejiang Jianfeng Pharmaceutical Co., Ltd. | Freeze-dried Powder Injection |
304. Jiangsu Huapeng Pharmaceutical Factory | High Dose Injection |
305. Yangzijiang Pharmaceutical Co., Ltd. | Syrup |
306. Chongqing Runkang Pharmaceutical Co., Ltd. | Freeze-dried Powder Injection |
307. Zhejiang Tianhuang Pharmaceutical Co., Ltd. | Capsule, Granule |
308. Shandong Lukang Pharmaceutical Group | Powder Injection |
309. Yangzhou Pharmaceutical Factory | Freeze-dried Powder Injection |
310. Shandong Xinhua Pharmaceutical Co., Ltd. | High Dose Injection, Low Dose Injection, Tablet, Capsule |
311. Hangzhou Sanofi-Synthelabo Minshen Pharma Co., Ltd. | Freeze-dried Powder Injection |
312. Hangzhou Minsheng Pharmaceutical Group | Powder Injection (Penicillin), Freeze-dried Powder Injection, High Dose Injection, Tablet |
313. Henan Wanxi Pharmaceutical Co., Ltd. | Granule, Tablet |
314. Zhejiang Kangle Group Co., Ltd. | Powder Injection (Penicillin), High Dose Injection |
315. Shijianzhuang 1st Pharmaceutical Factory | Tablet, Capsule, Granule (Cephalosporin) |
316. Sichuan Kelun Pharmaceutical Factory | High Dose Injection |
317. Xinchang Pharma Factory of Zhejiang Pharma Co., Ltd. | Raw Material |
318. Shantou Mingzhi Pharmaceutical Co., Ltd. | Freeze-dried Powder Injection |
319. Huaiyin 2nd Pharmaceutical Factory | High Dose Injection |
320. Shandong Kexing Bio-products Co., Ltd. | Recombinant Granulocyte-macrophageStimulus Factor workshop |
321. Anshan Weibang Pharmaceutical Co., Ltd. | High Dose Injection, Freeze-dried Powder Injection |
322. Shenyang North Pharmaceutical Factory | High Dose Injection |
323. Hebei Pharmaceutical (Group) Co., Ltd. | Raw Material (Penicillin, Cephalosporin) |
324. Fujian Jiahua Pharmaceutical Co., Ltd. | High Dose Injection |
325. Tianjin Pharmaceutical Lianshui Co., Ltd. | Low Dose Injection |
326. Nanjing Benyuan-Dongyuan Pharma Co., Ltd. | Tablet, Granule (Penicillin) |
327. Nanjing Pharmaceutical University Bio-products Co., Ltd. | Freeze-driedPowder Injection |
328. Henan Xinyi Pharmaceutical Co., Ltd. | Powder Injection (Cephalosporin) |
329. Henan North Pharmaceutical Factory | Raw Material, Powder Injection (Cephalosporin) |
330. Luoyang Pharmaceutical Factory | High Dose Injection |
332. Gansu Shenlong Pharma Co., Ltd. | Powder Injection (Penicillin, Cephalosporin) |
331. Henan Xinxiang Zhengcheng Pharma Factory | High Dose Injection |
333. Zhejiang Medicine Science Academy Pharma Factory | Freeze-dried Powder Injection (Anti-tumor) |
334. Shenyang 1st Factory of Northeast Group | Powder Injection (Penicillin, Cephalosporin), Freeze-dried Powder Injection |
335. Guanxi Taoyuan Pharmaceutical Factory | High Dose Injection |
336. Hunan 2nd Hecheng Pharmaceutical Factory | Powder Injection |
337. Sichuan Pharmaceutical Co., Ltd. by Shares | Powder Injection (Penicillin, Cephalosporin) |
338. Chengdu Shuyang Pharmaceutical Factory | Freeze-dried Powder Injection |
339. Sichuan Changzheng Pharma Co., Ltd. | Raw Material |
340. Jiangxi Dongfeng Pharma Co., Ltd. | Powder Injection (Penicillin) |
341. Nanchang Yufeng Pharmaceutical Factory | Powder Injection (Cephalosporin) |
342. Shandong Lukang Pharmaceutical Group | Powder Injection |
343. Henan Puyang 2nd Pharmaceutical Factory | High Dose Injection |
344. Henan Xinyi Pharmaceutical Co., Ltd. | Freeze-dried Powder Injection |
345. Jinzhou Jiutai Pharmaceutical Co. Ltd. | High Dose Injection Powder Injection |
346. Dalian Deze Pharmaceutical Co., Ltd. | High Dose Injection |
347. Beijing Sihuan Bio-Engineering Products Factory | Recombinant Human Interferona2a, |
348. Henan Madison Ruifeng Pharma Co., Ltd. | Freeze-dried Powder Injection |
349. 505 Pharmaceutical Co., Ltd. | Tablet, Capsule, Granule |
350. Hubei Qianjiang Pharmaceutical Co., Ltd. | Freeze-dried Powder Injection |
Lehman Lee & Xu
China Lawyers, Notaries, Patent, Copyright and Trademark Agents
http://www.chinalaw.cc/
Beijing Office | Shanghai Office |
188, Beijing International Club
21 Jianguomenwai Dajie, Beijing 100020 China
Tel.: (86)(10) 8532-1919
Fax: (86)(10) 8532-1999
Email: mail@chinalaw.cc | Suite 1902, Central Plaza
227 North Huangpi Road
Shanghai 200003, China
Tel: +86-21 6375-8240-1
Fax: +86-21 6375-8705
Email: shanghai@chinalaw.cc |
To unsubscribe from this newsletter send an email to unsubscribe_lp@chinalaw.cc Please include the email address to which the newsletter is being sent (not a forwarded address) in the body of the email.
The China Lex Pharma Law Newsletter is intended to be used for news purposes only. It should not be taken as comprehensive legal advice, and Lehman, Lee & Xu will not be held responsible for any such reliance on its contents.
